IBDEI0GB ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16343,2)
 ;;=^5063409
 ;;^UTILITY(U,$J,358.3,16344,0)
 ;;=Z85.42^^64^786^23
 ;;^UTILITY(U,$J,358.3,16344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16344,1,3,0)
 ;;=3^Personal Hx Malig Neop Parts of Uterus
 ;;^UTILITY(U,$J,358.3,16344,1,4,0)
 ;;=4^Z85.42
 ;;^UTILITY(U,$J,358.3,16344,2)
 ;;=^5063419
 ;;^UTILITY(U,$J,358.3,16345,0)
 ;;=Z79.01^^64^787^18
 ;;^UTILITY(U,$J,358.3,16345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16345,1,3,0)
 ;;=3^L/T (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,16345,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,16345,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,16346,0)
 ;;=Z76.0^^64^787^20
 ;;^UTILITY(U,$J,358.3,16346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16346,1,3,0)
 ;;=3^Medication Renewal
 ;;^UTILITY(U,$J,358.3,16346,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,16346,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,16347,0)
 ;;=R79.1^^64^787^2
 ;;^UTILITY(U,$J,358.3,16347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16347,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,16347,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,16347,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,16348,0)
 ;;=Z95.810^^64^787^1
 ;;^UTILITY(U,$J,358.3,16348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16348,1,3,0)
 ;;=3^AICD
 ;;^UTILITY(U,$J,358.3,16348,1,4,0)
 ;;=4^Z95.810
 ;;^UTILITY(U,$J,358.3,16348,2)
 ;;=^5063674
 ;;^UTILITY(U,$J,358.3,16349,0)
 ;;=I25.3^^64^787^3
 ;;^UTILITY(U,$J,358.3,16349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16349,1,3,0)
 ;;=3^Aneurysm of Heart
 ;;^UTILITY(U,$J,358.3,16349,1,4,0)
 ;;=4^I25.3
 ;;^UTILITY(U,$J,358.3,16349,2)
 ;;=^5007112
 ;;^UTILITY(U,$J,358.3,16350,0)
 ;;=I35.9^^64^787^4
 ;;^UTILITY(U,$J,358.3,16350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16350,1,3,0)
 ;;=3^Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16350,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,16350,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,16351,0)
 ;;=Z95.2^^64^787^32
 ;;^UTILITY(U,$J,358.3,16351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16351,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,16351,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,16351,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,16352,0)
 ;;=I74.9^^64^787^5
 ;;^UTILITY(U,$J,358.3,16352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16352,1,3,0)
 ;;=3^Arterial Embolism/Thrombosis,Unspec
 ;;^UTILITY(U,$J,358.3,16352,1,4,0)
 ;;=4^I74.9
 ;;^UTILITY(U,$J,358.3,16352,2)
 ;;=^5007805
 ;;^UTILITY(U,$J,358.3,16353,0)
 ;;=I48.91^^64^787^6
 ;;^UTILITY(U,$J,358.3,16353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16353,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,16353,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,16353,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,16354,0)
 ;;=I48.92^^64^787^7
 ;;^UTILITY(U,$J,358.3,16354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16354,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,16354,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,16354,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,16355,0)
 ;;=Z95.0^^64^787^8
 ;;^UTILITY(U,$J,358.3,16355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16355,1,3,0)
 ;;=3^Cardiac Pacemaker
 ;;^UTILITY(U,$J,358.3,16355,1,4,0)
 ;;=4^Z95.0
 ;;^UTILITY(U,$J,358.3,16355,2)
 ;;=^5063668
 ;;^UTILITY(U,$J,358.3,16356,0)
 ;;=I42.8^^64^787^9
 ;;^UTILITY(U,$J,358.3,16356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16356,1,3,0)
 ;;=3^Cardiomyopathies NEC
 ;;^UTILITY(U,$J,358.3,16356,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,16356,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,16357,0)
 ;;=I65.29^^64^787^10
 ;;^UTILITY(U,$J,358.3,16357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16357,1,3,0)
 ;;=3^Carotid Artery Occlusion/Stenosis,Unspec
 ;;^UTILITY(U,$J,358.3,16357,1,4,0)
 ;;=4^I65.29
 ;;^UTILITY(U,$J,358.3,16357,2)
 ;;=^5007363
 ;;^UTILITY(U,$J,358.3,16358,0)
 ;;=I23.0^^64^787^11
 ;;^UTILITY(U,$J,358.3,16358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16358,1,3,0)
 ;;=3^Certain Sequelae of MI
 ;;^UTILITY(U,$J,358.3,16358,1,4,0)
 ;;=4^I23.0
 ;;^UTILITY(U,$J,358.3,16358,2)
 ;;=^5007094
 ;;^UTILITY(U,$J,358.3,16359,0)
 ;;=I82.509^^64^787^12
 ;;^UTILITY(U,$J,358.3,16359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16359,1,3,0)
 ;;=3^Chr DVT/Embolism Lower Extremity,Unspec
 ;;^UTILITY(U,$J,358.3,16359,1,4,0)
 ;;=4^I82.509
 ;;^UTILITY(U,$J,358.3,16359,2)
 ;;=^5133628
 ;;^UTILITY(U,$J,358.3,16360,0)
 ;;=K70.0^^64^787^13
 ;;^UTILITY(U,$J,358.3,16360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16360,1,3,0)
 ;;=3^Chronic Liver Disease
 ;;^UTILITY(U,$J,358.3,16360,1,4,0)
 ;;=4^K70.0
 ;;^UTILITY(U,$J,358.3,16360,2)
 ;;=^5008784
 ;;^UTILITY(U,$J,358.3,16361,0)
 ;;=E56.1^^64^787^37
 ;;^UTILITY(U,$J,358.3,16361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16361,1,3,0)
 ;;=3^Vitamin K Deficiency
 ;;^UTILITY(U,$J,358.3,16361,1,4,0)
 ;;=4^E56.1
 ;;^UTILITY(U,$J,358.3,16361,2)
 ;;=^5002801
 ;;^UTILITY(U,$J,358.3,16362,0)
 ;;=Z96.649^^64^787^16
 ;;^UTILITY(U,$J,358.3,16362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16362,1,3,0)
 ;;=3^Hip Joint Replacement
 ;;^UTILITY(U,$J,358.3,16362,1,4,0)
 ;;=4^Z96.649
 ;;^UTILITY(U,$J,358.3,16362,2)
 ;;=^5063704
 ;;^UTILITY(U,$J,358.3,16363,0)
 ;;=Z96.659^^64^787^17
 ;;^UTILITY(U,$J,358.3,16363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16363,1,3,0)
 ;;=3^Knee Joint Replacement
 ;;^UTILITY(U,$J,358.3,16363,1,4,0)
 ;;=4^Z96.659
 ;;^UTILITY(U,$J,358.3,16363,2)
 ;;=^5063708
 ;;^UTILITY(U,$J,358.3,16364,0)
 ;;=I69.90^^64^787^19
 ;;^UTILITY(U,$J,358.3,16364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16364,1,3,0)
 ;;=3^Late Effects CVA
 ;;^UTILITY(U,$J,358.3,16364,1,4,0)
 ;;=4^I69.90
 ;;^UTILITY(U,$J,358.3,16364,2)
 ;;=^5007551
 ;;^UTILITY(U,$J,358.3,16365,0)
 ;;=I34.8^^64^787^21
 ;;^UTILITY(U,$J,358.3,16365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16365,1,3,0)
 ;;=3^Mitral Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,16365,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,16365,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,16366,0)
 ;;=I23.0^^64^787^23
 ;;^UTILITY(U,$J,358.3,16366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16366,1,3,0)
 ;;=3^Mural Thrombus
 ;;^UTILITY(U,$J,358.3,16366,1,4,0)
 ;;=4^I23.0
 ;;^UTILITY(U,$J,358.3,16366,2)
 ;;=^5007094
 ;;^UTILITY(U,$J,358.3,16367,0)
 ;;=I73.9^^64^787^28
 ;;^UTILITY(U,$J,358.3,16367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16367,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16367,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,16367,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,16368,0)
 ;;=Z86.79^^64^787^29
 ;;^UTILITY(U,$J,358.3,16368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16368,1,3,0)
 ;;=3^Personal Hx of Circulatory System Disease NEC
 ;;^UTILITY(U,$J,358.3,16368,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,16368,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,16369,0)
 ;;=Z86.72^^64^787^30
 ;;^UTILITY(U,$J,358.3,16369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16369,1,3,0)
 ;;=3^Personal Hx of Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,16369,1,4,0)
 ;;=4^Z86.72
 ;;^UTILITY(U,$J,358.3,16369,2)
 ;;=^5063476
 ;;^UTILITY(U,$J,358.3,16370,0)
 ;;=Z86.718^^64^787^31
 ;;^UTILITY(U,$J,358.3,16370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16370,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism NEC
 ;;^UTILITY(U,$J,358.3,16370,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,16370,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,16371,0)
 ;;=I26.99^^64^787^33
 ;;^UTILITY(U,$J,358.3,16371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16371,1,3,0)
 ;;=3^Pulmonary Embolism NEC
 ;;^UTILITY(U,$J,358.3,16371,1,4,0)
 ;;=4^I26.99
 ;;^UTILITY(U,$J,358.3,16371,2)
 ;;=^5007150
 ;;^UTILITY(U,$J,358.3,16372,0)
 ;;=G45.9^^64^787^35
 ;;^UTILITY(U,$J,358.3,16372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16372,1,3,0)
 ;;=3^TIA,Unspec
 ;;^UTILITY(U,$J,358.3,16372,1,4,0)
 ;;=4^G45.9
